|
Market Closed -
Xetra
07:17:34 2026-09-07 am EDT
|
After hours 01:33:47 pm | |||
| 13.60 EUR | -3.41% |
|
13.57 | -0.22% |
| Jul. 03 | Genfit soars on news of U.S. reimbursement for a product |  |
| Jul. 03 | Genfit's Liver Disease Blood Test Approved for US Medicare Reimbursement | MT |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
Data source:
GENFIT(GNFT)
EBIT - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Data source:
GENFIT(GNFT)
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| - | |||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
Data source:
GENFIT(GNFT)
EBIT
Dividend / Share (DPS)
Data source:
GENFIT(GNFT)
Cash or Net Debt
- Stock Market
- Stocks
- GNFT Stock
- XUP Stock
- Consensus GENFIT
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
